Literature DB >> 184690

Metabolism of mono- and diacylglycerols in subcutaneous adipose tissue of obese and normal-weight subjects.

P Arner, L Liljeqvist, J Ostman.   

Abstract

Tissue monoacylglycerols (MG), diacylglycerols (DG), free fatty acids (FFA), and cyclic AMP (cAMP) and release of FFA and glycerol have been studied in vitro in subcutaneous adipose tissue of 6 obese and 7 normal-weight subjects. The tissue was incubated without or with 6 X 10(-5) mol/l of isoprenaline (ISNA). The DG level and the fat cell volume were strongly interrelated (r=+0.95, p less than 0.001). The concentration of DG was increased (p less than 0.05) in obesity. The changes in DG and MG were significantly interrelated (r=+0.65, p less than 0.05) during basal incubation. ISNA increased the DG concentration in a way that was correlated (r=+0.81, p less than 0.001) with the ISNA-induced glycerol release. This indicates that 1) the basal metabolic activities of MG and DG lipase are similar and 2) DG lipase is an important rate limiting factor in lipolysis. Without ISNA, tissue FFA and the release of FFA and glycerol were significantly increased in the obese patients. As a mean, MG and DG did not accumulate in the basal state in the two patient groups. The findings indicate that basal lipolysis was increased in obesity. This was probably due to increased basal metabolic activity of triacylglycerol lipase, since the basal cAMP levels were similar in the two patient groups. In the presence of ISNA, the production of FFA and the glycerol release were similar in both patient groups, as was the increase in tissue DG. Also the ISNA-induced maximal level of cAMP was similar in the two groups. With ISNA, a small increment of MG was observed in adipose tissue of the normal-weight subjects. Taking all metabolites into account, the rate of lipolysis as well as the activation of triacylglycerol lipase via cAMP in the presence of ISNA appeared to be unaltered in obesity. Separate experiments with 1-14C-glycerol provided further evidence for the existence of a MG pathway for the esterification of FFA.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 184690     DOI: 10.1111/j.0954-6820.1976.tb08218.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  5 in total

1.  Post-exercise adipose tissue and skeletal muscle lipid metabolism in humans: the effects of exercise intensity.

Authors:  N A Mulla; L Simonsen; J Bülow
Journal:  J Physiol       Date:  2000-05-01       Impact factor: 5.182

2.  Functional evidence that alpha 2A-adrenoceptors are responsible for antilipolysis in human abdominal fat cells.

Authors:  G Tarkovács; C Blandizzi; E S Vizi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-01       Impact factor: 3.000

3.  LMNA mutations, skeletal muscle lipid metabolism, and insulin resistance.

Authors:  Michael Boschmann; Stefan Engeli; Cedric Moro; Angelika Luedtke; Frauke Adams; Kerstin Gorzelniak; Gabriele Rahn; Anja Mähler; Kerstin Dobberstein; Antje Krüger; Saskia Schmidt; Simone Spuler; Friedrich C Luft; Steven R Smith; Hartmut H-J Schmidt; Jens Jordan
Journal:  J Clin Endocrinol Metab       Date:  2010-02-03       Impact factor: 5.958

4.  Lipolysis defect in people with obesity who undergo metabolic surgery.

Authors:  Mikael Rydén; Daniel P Andersson; Maria I Kotopouli; Erik Stenberg; Erik Näslund; Anders Thorell; Thorkild I A Sørensen; Peter Arner
Journal:  J Intern Med       Date:  2022-06-07       Impact factor: 13.068

5.  Atrial natriuretic peptide induces postprandial lipid oxidation in humans.

Authors:  Andreas L Birkenfeld; Petra Budziarek; Michael Boschmann; Cedric Moro; Frauke Adams; Gabriele Franke; Michel Berlan; Marie A Marques; Fred C G J Sweep; Friedrich C Luft; Max Lafontan; Jens Jordan
Journal:  Diabetes       Date:  2008-10-03       Impact factor: 9.461

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.